Patent details
EP4106757
Title:
METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR TREATING RESPIRATORY DISEASE MEDIATED BY ALPHA-1 ANTITRYPSIN DEFICIENCY
Basic Information
- Publication number:
- EP4106757
- PCT Application Number:
- GB2021050653
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP217143452
- PCT Publication Number:
- WO2021209739
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR TREATING RESPIRATORY DISEASE MEDIATED BY ALPHA-1 ANTITRYPSIN DEFICIENCY
- French Title of Invention:
- PROCÉDÉS IMPLIQUANT L'ALVÉLESTAT INHIBITEUR DE L'ÉLASTASE NEUTROPHILE POUR LE TRAITEMENT D'UNE MALADIE RESPIRATOIRE INDUITE PAR UNE DÉFICIENCE EN ALPHA-1 ANTITRYPSINE
- German Title of Invention:
- METHODEN BEINHALTEND NEUTROPHILE ELASTASE INHIBITOR ALVELESTAT ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNG AUFGRUND VON ALPHA-1 ANTITRYPSIN MANGEL
- SPC Number:
-
Dates
- Filing date:
- 16/03/2021
- Grant date:
- 23/08/2023
- EP Publication Date:
- 28/12/2022
- PCT Publication Date:
- 21/10/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/08/2023
- EP B1 Publication Date:
- 23/08/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 16/03/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/08/2023
-
-
- Name:
- Mereo Biopharma 4 Limited
- Address:
- 1 Cavendish Place, London
Greater London W1G 0QF, United Kingdom (GB)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 24/08/2023
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- PARKIN, Jacqueline
- Address:
- United Kingdom (GB)
Priority
1
- Priority Number:
- 202005520
- Priority Date:
- 16/04/2020
- Priority Country:
- United Kingdom (GB)
2
- Priority Number:
- 202005519
- Priority Date:
- 16/04/2020
- Priority Country:
- United Kingdom (GB)
3
- Priority Number:
- 202062706195 P
- Priority Date:
- 04/08/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/444;
A61K 45/06;
A61P 11/00;
A61P 29/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202334
- Publication date:
- 23/08/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202426
- Publication date:
- 26/06/2024
- Description:
- Opposition procedure started
3
- Issue number:
- 202335
- Publication date:
- 30/08/2023
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 31/03/2026
- Annual Fee Number:
- 6
- Annual Fee Amount:
- 66 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 27/02/2025
- Last Annual Fee Paid Number:
- 5
- Last Annual Fee Paid Amount:
- 52 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM